Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 178

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Biocompatible, Purified VEGF-A mRNA Improves Cardiac Function after Intracardiac Injection 1 Week Post-myocardial Infarction in Swine

Open access
Carlsson, Leif, Clarke, Jonathan C., Yen, Christopher, Gregoire, Francine, Albery, Tamsin, Billger, Martin, Egnell, Ann-Charlotte, Gan, Li-Ming, Jennbacken, Karin, Johansson, Edvin, Linhardt, Gunilla, Martinsson, Sofia, Sadiq, Muhammad Waqas, Witman, Nevin, Wang, Qing-Dong, Chen, Chien-Hsi, Wang, Yu-Ping, Lin, Susan, Ticho, Barry, Hsieh, Patrick C.H., Chien, Kenneth R., Fritsche-Danielson, Regina · 2018 · Molecular Therapy - Methods & Clinical Development

Abstract

mRNA can direct dose-dependent protein expression in cardiac muscle without genome integration, but to date has not been shown to improve cardiac function in a safe, clinically applicable way. Herein, we report that a purified and optimized mRNA in a biocompatible citrate-saline formulation is tissue specific, long acting, and does not stimulate an immune response. In small- and large-animal, permanent occlusion myocardial infarction models, VEGF-A 165 mRNA improves systolic ventricular function and limits myocardial damage. Following a single administration a week post-infarction in mini pigs, left ventricular ejection fraction, inotropy, and ventricular compliance improved, border zone arteriolar and capillary density increased, and myocardial fibrosis decreased at 2 months post-treatment. Purified VEGF-A mRNA establishes the feasibility of improving cardiac function in the sub-acute therapeutic window and may represent a new class of therapies for ischemic injury.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.omtm.2018.04.003

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 178

Metadata

Authors
Carlsson, L., Clarke, J. C., Yen, C., Gregoire, F., Albery, T., Billger, M., Egnell, A.-C., Gan, L.-M., Jennbacken, K., Johansson, E., Linhardt, G., Martinsson, S., Sadiq, M. W., Witman, N., Wang, Q.-D., Chen, C.-H., Wang, Y.-P., Lin, S., Ticho, B., Hsieh, P. C. H., Chien, K. R., & Fritsche-Danielson, R.
Venue
Molecular Therapy - Methods & Clinical Development
Publisher
Elsevier BV
Published
2018-06
Volume
9
Pages
330-346
ISSN
2329-0501 (ISSN-L)
OpenAlex
W2797607167
Cited by
178
References
19
FWCI
10.84
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biocompatible, Purified VEGF-A mRNA Improves Cardiac Function after Intracardiac Injection 1 Week Post-myocardial Infarction in Swine. https://app.cochat.ai/papers/10.1016/j.omtm.2018.04.003
The paper
Carlsson, L., Clarke, J. C., Yen, C., Gregoire, F., Albery, T., Billger, M., Egnell, A.-C., Gan, L.-M., Jennbacken, K., Johansson, E., Linhardt, G., Martinsson, S., Sadiq, M. W., Witman, N., Wang, Q.-D., Chen, C.-H., Wang, Y.-P., Lin, S., Ticho, B., . . . Fritsche-Danielson, R. (2018). Biocompatible, Purified VEGF-A mRNA Improves Cardiac Function after Intracardiac Injection 1 Week Post-myocardial Infarction in Swine. Molecular Therapy - Methods & Clinical Development. https://doi.org/10.1016/j.omtm.2018.04.003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.